{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:14:57Z","timestamp":1778069697303,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clml.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T22:51:41Z","timestamp":1772405501000},"page":"e669-e677.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3835-5750","authenticated-orcid":false,"given":"Jonathan A.","family":"Baron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Chelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2950-9823","authenticated-orcid":false,"given":"Ian","family":"Messing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-4197","authenticated-orcid":false,"given":"Ann","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0786-8035","authenticated-orcid":false,"given":"Omar","family":"Elghawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasheed","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Rook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Villasenor-Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harper","family":"Hubbeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-5271","authenticated-orcid":false,"given":"Stefan K.","family":"Barta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-5086","authenticated-orcid":false,"given":"Michael","family":"LaRiviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clml.2026.02.012_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.clml.2026.02.012_bib0002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2026.02.012_bib0003","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clml.2026.02.012_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpainsymman.2012.01.012","article-title":"Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma","volume":"45","author":"Wright","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clml.2026.02.012_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1498855","article-title":"Total skin electron beam therapy","volume":"15","author":"Specht","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.clml.2026.02.012_bib0006","first-page":"26","article-title":"Clinical application of total skin electron beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy) treatment schedule","volume":"15","author":"Georgakopoulos","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clml.2026.02.012_bib0007","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.clml.2026.02.012_bib0008","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood.V89.8.3062","article-title":"Mycosis fungoides and total skin electron beam radiation","volume":"89","author":"Jones","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2026.02.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13478","article-title":"Low dose total skin electron beam therapy for the management of T cell cutaneous lymphomas","volume":"33","author":"Georgakopoulos","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.clml.2026.02.012_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2026.02.012_bib0011","article-title":"Low dose total skin electron beam therapy for the management of T cell cutaneous lymphomas","volume":"33","author":"Ioannis","year":"2020","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.clml.2026.02.012_bib0012","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2026.02.012_bib0013","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.critrevonc.2015.12.018","article-title":"Panoptic clinical review of the current and future treatment of relapsed\/refractory T-cell lymphomas: cutaneous T-cell lymphomas","volume":"99","author":"Zinzani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.clml.2026.02.012_bib0014","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2019.01.02","article-title":"Systemic therapy of cutaneous T-cell lymphoma (CTCL)","volume":"8","author":"Alpdogan","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"8","key":"10.1016\/j.clml.2026.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jdv.20350","article-title":"Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: real-world data from a multicentre study","volume":"39","author":"Nikolaou","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.clml.2026.02.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7625926","article-title":"Mogamulizumab multimodality therapy with systemic retinoids, interferon, or extracorporeal photopheresis for advanced cutaneous T-cell lymphoma","volume":"2023","author":"Weiner","year":"2023","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.clml.2026.02.012_bib0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2020.12.026","article-title":"The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: current and future approaches","volume":"84","author":"Weiner","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.clml.2026.02.012_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/bjh.15905","article-title":"Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and S\u00e9zary syndrome","volume":"186","author":"Jothishankar","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.clml.2026.02.012_bib0019","article-title":"Low-dose total skin electron beam therapy combined with mogamulizumab for refractory mycosis fungoides and Sezary syndrome","volume":"6","author":"Fong","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clml.2026.02.012_bib0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0360-3016(86)90361-5","article-title":"Dose distribution in total skin electron beam irradiation using the six-field technique","volume":"12","author":"Niroomand-Rad","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.clml.2026.02.012_bib0021","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1-2","key":"10.1016\/j.clml.2026.02.012_bib0022","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000069773","article-title":"Biochemical and clinical aspects of methotrexate neurotoxicity","volume":"49","author":"Vezmar","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clml.2026.02.012_sbref0023","series-title":"StatPearls","article-title":"Methotrexate","author":"Hanoodi","year":"2024"},{"issue":"SUPPL 6","key":"10.1016\/j.clml.2026.02.012_bib0024","article-title":"Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines","volume":"22","author":"Peterson","year":"2011","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clml.2026.02.012_bib0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2013.04.042","article-title":"Results of a 5-week schedule of modern total skin electron beam radiation therapy","volume":"86","author":"Morris","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2026.02.012_bib0026","unstructured":"ClinicalTrials.gov. LD-TSEBT and Mogamulizumab in Patients with Mycosis Fungoides and S\u00e9zary Syndrome. National Library of Medicine, US. https:\/\/clinicaltrials.gov\/study\/NCT04256018"},{"key":"10.1016\/j.clml.2026.02.012_bib0027","unstructured":"ClinicalTrials.gov. Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly over 12 Months. National Library of Medicine, US. https:\/\/clinicaltrials.gov\/study\/NCT05357794"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:37:23Z","timestamp":1778067443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2152265026000625"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.02.012","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}